C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy

Journal of the American College of Cardiology

Volumn 31, Issue 7, 1998, Pages 1460-1465

  Morrow, David A ^a   Rifai, Nader ^b   Antman, Elliott M ^a   Weiner, Debra L ^b   McCabe, Carolyn H ^a   Cannon, Christopher P ^a   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; TROPONIN T;

ADULT; ARTICLE; BLOOD CLOT LYSIS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; TROPONIN; TROPONIN T;

EID: 0031746866     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00136-3     Document Type: Article

References (41)

1. Fuster V., Badimon L., Badimon J.J., Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
2. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
3. Alexander R.W. Inflammation and coronary artery disease. N Engl J Med. 331:1994;468-469.
4. Munro J.M., Cotran R.S. The pathogenesis of atherosclerosis atherogenesis and inflammation . Lab Invest. 58:1988;249-261.
5. Libby P., Hansson G.K. Involvement of the immune system in human atherogenesis current knowledge and unanswered questions . Lab Invest. 64:1991;5-15.
6. Kushner I., Broder M.L., Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest. 61:1978;235-242.
7. Heinrich J., Schulte H., Schonfeld R., Kohler E., Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 73:1995;374-379.
8. Juhan-Vague I., Alessi M.C., Joly P., et al. Plasma plasminogen activator inhibitor-1 in angina pectoris influence of plasma insulin and acute-phase response . Arteriosclerosis. 9:1989;362-367.
9. Berk B.C., Weintraub W.S., Alexander R.W. Elevation of C-reactive protein in "active" coronary artery disease. Am J Cardiol. 65:1990;168-172.
10. Mendall M.A., Patel P., Ballam L., Strachan D., Northfield T.C. C reactive protein and its relation to cardiovascular risk factors a population based cross sectional study . BMJ. 312:1996;1061-1065.
11. de Beer F.C., Hind C.R., Fox K.M., Allan R.M., Maseri A., Pepys M.B. Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction. Br Heart J. 47:1982;239-243.
12. Pietila K., Harmoinen A., Poyhonen L., Ruosteenoja R. C-reactive protein in subendocardial and transmural myocardial infarcts. Clin Chem. 32:1986;1596-1597.
13. Pietila K., Harmoinen A., Hermens W., Simoons M.L., Van de Werf F., Verstraete M. Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart J. 14:1993;915-919.
14. Voulgari F., Cummins P., Gardecki T.I., Beeching N.J., Stone P.C., Stuart J. Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. Br Heart J. 48:1982;352-356.
15. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 336:1997;973-979.
16. Kuller L.H., Tracy R.P., Shaten J., Meilahn E.N. Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study Multiple Risk Factor Intervention Trial . Am J Epidemiol. 144:1996;537-547.
17. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . N Engl J Med. 332:1995;635-641.
18. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . Lancet. 349:1997;462-466.
19. Antman E., Grudzien C., Sacks D. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 273:1995;1279-1282.
20. Lindahl B., Venge P., Wallentin L. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary disease the FRISC Study Group . Circulation. 93:1996;1651-1657.
21. Lindahl B., Andren B., Ohlsson J., Venge P., Wallentin P. Risk stratification in unstable coronary artery disease additive value of troponin T determinations and pre-discharge exercise tests: FRISC Study Group . Eur Heart J. 18:1997;762-770.
22. Ohman E., Armstrong P., Christenson R., et al. Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med. 335:1996;1333-1341.
23. Hamm C., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 327:1992;146-150.
24. Liuzzo G., Biasucci L.M., Gallimore J.R., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med. 331:1994;417-424.
25. Antman E., Sacks D., Rifai N., McCabe C., Cannon C., Braunwald E. Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes. J Am Coll Cardiol. 31:1998;326-330.
26. Dose-ranging trial of enoxaparin for unstable angina results of TIMI 11A . J Am Coll Cardiol. 29:1997;1474-1482.
27. Muller-Bardorff M., Freitag H., Scheffold T., Remppis A., Kubler W., Katus H.A. Development and characterization of a rapid assay for bedside determinations of cardiac troponin T. Circulation. 92:1995;2869-2875.
28. Antman E.M., Grudzien C., Sacks D.B. Evaluation of a rapid bedside assay for detection of serum cardiac troponin T. JAMA. 273:1995;1279-1282.
29. Braunwald E, Mark D, Jones R, et al. Unstable angina: diagnosis and management: clinical practice guidline number 10. Rockville (MD): Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, Public Health Service, U.S. Department of Health and Human Services; 1994:154. AHCPR Publication No. 94-0602.
30. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction results of the TIMI IIIB trial (Thrombolysis in Myocardial Ischemia) . Circulation. 89:1994;1545-1556.
31. Kohchi K., Takebayashi S., Hiroki T., Nobuyoshi M. Significance of adventitial inflammation of the coronary artery in patients with unstable angina results at autopsy . Circulation. 71:1985;709-716.
32. Sato T., Takebayashi S., Kohchi K. Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Histological data on 14 autopsied patients. Atherosclerosis. 68:1987;191-197.
33. Serneri G.G., Abbate R., Gori A.M., et al. Transient intermittent lymphocyte activation is responsible for the instability of angina. Circulation. 86:1992;790-797.
34. van der Wal A.C., Becker A.E., van der Loos C.M., Das P.K. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:1994;36-44.
35. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877.
36. Miyao Y., Yasue H., Ogawa H., et al. Elevated plasma interleukin-6 levels in patients with acute myocardial infarction. Am Heart J. 126:1993;1299-1304.
37. Maseri A., Biasucci L.M., Liuzzo G. Inflammation in ischaemic heart disease. BMJ. 312:1996;1049-1050.
38. Deodhar S.D. C-reactive protein the best laboratory indicator available for monitoring disease activity . Cleve Clin J Med. 56:1989;126-130.
39. Vigushin D.M., Pepys M.B., Hawkins P.N. Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease. J Clin Invest. 91:1993;1351-1357.
40. Shine B., de Beer F.C., Pepys M.B. Solid phase radioimmunoassays for human C-reactive protein. Clin Chim Acta. 117:1981;13-23.
41. Pepys M.B., Baltz M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 34:1983;141-212.